SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-138359
Filing Date
2023-05-08
Accepted
2023-05-08 16:59:35
Documents
6
Effectiveness Date
2023-05-08

Document Format Files

Seq Description Document Type Size
1 S-8 d413459ds8.htm S-8 54552
2 EX-5.1 d413459dex51.htm EX-5.1 12238
3 EX-23.2 d413459dex232.htm EX-23.2 1565
4 EX-FILING FEES d413459dexfilingfees.htm EX-FILING FEES 18868
5 GRAPHIC g413459dsp9.jpg GRAPHIC 4228
6 GRAPHIC g413459dsp9a.jpg GRAPHIC 3284
  Complete submission text file 0001193125-23-138359.txt   98871
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271728 | Film No.: 23898637
SIC: 2836 Biological Products, (No Diagnostic Substances)